Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin versus heparin during PCI for coronary chronic total occlusion
ChiCTR1900024196Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Jul 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of bivalirudin and heparin in Chronic coronary occlusion (CTO) (2 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoints: Electrocardiogram, Echocardiography and 4 more. Started Jul 2019; status: recruiting.
02
Drugs
bivalirudinheparin
03
Conditions
Chronic coronary occlusion (CTO)
Beyond the preview
Go deeper on ChiCTR1900024196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024196.